Literature DB >> 2586525

Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2.

C C Bascom1, J R Wolfshohl, R J Coffey, L Madisen, N R Webb, A R Purchio, R Derynck, H L Moses.   

Abstract

Regulation of transforming growth factor beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 mRNAs in murine fibroblasts and keratinocytes by TGF beta 1 and TGF beta 2 was studied. In quiescent AKR-2B fibroblasts, in which TGF beta induces delayed stimulation of DNA synthesis, TGF beta 1 autoregulation of TGF beta 1 expression was observed as early as 1 h, with maximal induction (25-fold) after 6 to 12 h. Increased expression of TGF beta 1 mRNA was accompanied by increased TGF beta protein production into conditioned medium of AKR-2B cells. Neither TGF beta 2 nor TGF beta 3 mRNA, however, was significantly induced, but both were apparently down regulated at later times by TGF beta 1. Protein synthesis was not required for autoinduction of TGF beta 1 mRNA in AKR-2B cells. Nuclear run-on analyses and dactinomycin experiments indicated that autoregulation of TGF beta 1 expression is complex, involving both increased transcription and message stabilization. In contrast to TGF beta 1, TGF beta 2 treatment of quiescent AKR-2B cells increased expression of TGF beta 1, TGF beta 2, and TGF beta 3 mRNAs, but with different kinetics. Autoinduction of TGF beta 2 mRNA occurred rapidly with maximal induction at 1 to 3 h, enhanced TGF beta 3 mRNA levels were observed after 3 h, and increased expression of TGF beta 1 occurred later, with maximal mRNA levels obtained after 12 to 24 h. Nuclear run-on analyses indicated that TGF beta 2 regulation of TGF beta 2 and TGF beta 3 mRNA levels is transcriptional, while TGF beta 2 induction of TGF beta 1 expression most likely involves both transcriptional and posttranscriptional controls. In BALB/MK mouse keratinocytes, minimal autoinduction of TGF beta 1 occurred at only the 12- and 24-h time points and protein synthesis was required for this autoinduction. The results of this study provide an example in which TGF beta 1 and TGF beta 2 elicit different responses and demonstrate that expression of TGF beta 1, and TGF beta 3 are regulated differently. The physiological relevance of TGF beta 1 autoinduction in the context of wound healing is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2586525      PMCID: PMC363721          DOI: 10.1128/mcb.9.12.5508-5515.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase.

Authors:  J M Taylor; R Illmensee; J Summers
Journal:  Biochim Biophys Acta       Date:  1976-09-06

2.  Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines.

Authors:  J Massagué; B Like
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

3.  p1B15: a cDNA clone of the rat mRNA encoding cyclophilin.

Authors:  P E Danielson; S Forss-Petter; M A Brow; L Calavetta; J Douglass; R J Milner; J G Sutcliffe
Journal:  DNA       Date:  1988-05

4.  Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval.

Authors:  G D Shipley; R F Tucker; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  Transforming growth factor-beta increases transcription of the genes encoding the epidermal growth factor receptor and fibronectin in normal rat kidney fibroblasts.

Authors:  K L Thompson; R Assoian; M R Rosner
Journal:  J Biol Chem       Date:  1988-12-25       Impact factor: 5.157

6.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.

Authors:  M E Greenberg; E B Ziff
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

7.  New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.

Authors:  A B Roberts; M A Anzano; L C Lamb; J M Smith; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

8.  Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells.

Authors:  J C Jennings; S Mohan; T A Linkhart; R Widstrom; D J Baylink
Journal:  J Cell Physiol       Date:  1988-10       Impact factor: 6.384

9.  Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor.

Authors:  M Noda; K Yoon; C W Prince; W T Butler; G A Rodan
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

10.  Transforming growth factor production by chemically transformed cells.

Authors:  H L Moses; E L Branum; J A Proper; R A Robinson
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

View more
  54 in total

1.  A phorbol ester-regulated ribonuclease system controlling transforming growth factor beta 1 gene expression in hematopoietic cells.

Authors:  R E Wager; R K Assoian
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Preservation and expansion of the primate keratocyte phenotype by downregulating TGF-beta signaling in a low-calcium, serum-free medium.

Authors:  Tetsuya Kawakita; Edgar M Espana; Hua He; Robert Smiddy; Jean-Marie Parel; Chia-Yang Liu; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

Review 3.  TGF-beta: problems and prospects.

Authors:  M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-11

4.  Further characterization of ATP6V0A2-related autosomal recessive cutis laxa.

Authors:  Björn Fischer; Aikaterini Dimopoulou; Johannes Egerer; Thatjana Gardeitchik; Alexa Kidd; Dominik Jost; Hülya Kayserili; Yasemin Alanay; Iliana Tantcheva-Poor; Elisabeth Mangold; Cornelia Daumer-Haas; Shubha Phadke; Reto I Peirano; Julia Heusel; Charu Desphande; Neerja Gupta; Arti Nanda; Emma Felix; Elisabeth Berry-Kravis; Madhulika Kabra; Ron A Wevers; Lionel van Maldergem; Stefan Mundlos; Eva Morava; Uwe Kornak
Journal:  Hum Genet       Date:  2012-07-08       Impact factor: 4.132

5.  Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition.

Authors:  Yoko Katsuno; Dominique Stephan Meyer; Ziyang Zhang; Kevan M Shokat; Rosemary J Akhurst; Kohei Miyazono; Rik Derynck
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

6.  Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis.

Authors:  Katri Koli; Marjukka Myllärniemi; Kirsi Vuorinen; Kaisa Salmenkivi; Merja J Ryynänen; Vuokko L Kinnula; Jorma Keski-Oja
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 7.  Age-Related Macular Degeneration and Intracrine Biology: An Hypothesis.

Authors:  Richard N Re
Journal:  Ochsner J       Date:  2016

8.  Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.

Authors:  E P Böttinger; J L Jakubczak; I S Roberts; M Mumy; P Hemmati; K Bagnall; G Merlino; L M Wakefield
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

9.  Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta 1 (TGF-beta 1).

Authors:  K Hasegawa; Z Wang; M Inagaki; B I Carr
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

10.  Transforming growth factor-beta (TGF beta) inhibition of Epstein-Barr virus (EBV)- and interleukin-4 (IL-4)-induced immunoglobulin production in human B lymphocytes.

Authors:  K P Machold; D A Carson; M Lotz
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.